SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-039539
Filing Date
2019-08-13
Accepted
2019-08-13 16:13:39
Documents
2
Period of Report
2019-08-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv527548_8k.htm 8-K 19348
2 EXHIBIT 99.1 tv527548_ex99-1.htm EX-99.1 7893
  Complete submission text file 0001144204-19-039539.txt   28703
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33357 | Film No.: 191020772
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1